Seven Eight Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,580
| Closed | -$181K | – | 606 |
|
|
2022
Q4 | $181K | Buy |
+11,580
| New | +$181K | 0.05% | 378 |
|
|
2022
Q3 | – | Sell |
-14,772
| Closed | -$207K | – | 624 |
|
|
2022
Q2 | $207K | Buy |
14,772
+922
| +7% | +$12.9K | 0.08% | 337 |
|
|
2022
Q1 | $198K | Sell |
13,850
-8,169
| -37% | -$117K | 0.03% | 492 |
|
|
2021
Q4 | $300K | Sell |
22,019
-105,856
| -83% | -$1.44M | 0.05% | 360 |
|
|
2021
Q3 | $2.1M | Buy |
127,875
+46,200
| +57% | +$757K | 0.2% | 177 |
|
|
2021
Q2 | $1.38M | Buy |
+81,675
| New | +$1.38M | 0.19% | 179 |
|
|
2020
Q3 | – | Sell |
-17,820
| Closed | -$320K | – | 647 |
|
|
2020
Q2 | $320K | Sell |
17,820
-2,980
| -14% | -$53.5K | 0.23% | 179 |
|
|
2020
Q1 | $316K | Buy |
20,800
+7,126
| +52% | +$108K | 0.08% | 305 |
|
|
2019
Q4 | $270K | Sell |
13,674
-27,000
| -66% | -$533K | 0.01% | 588 |
|
|
2019
Q3 | $700K | Buy |
40,674
+30,600
| +304% | +$527K | 0.04% | 476 |
|
|
2019
Q2 | $178K | Buy |
+10,074
| New | +$178K | 0.01% | 555 |
|